Effect of HPV Education on Women's Knowledge
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorKahramanmaras Sutcu Imam University
About this trial
This interventional study aims to evaluate the effectiveness of an educational program on women's knowledge of Human Papillomavirus (HPV), HPV vaccination, and screening. HPV is a major public health concern worldwide and a leading cause of cervical cancer. Although cervical cancer is preventable through vaccination and early screening, HPV awareness among women remains limited in Türkiye. Educational interventions are therefore essential to improve knowledge and promote preventive health behaviors.
The study population consists of 110 women attending courses at the Suzan and Abdulhakim Bilgili Public Education Center in Onikişubat, Kahramanmaraş, Türkiye, between August 2025 and December 2025. No formal sample size calculation was performed. Instead, 80 women who met the inclusion criteria and voluntarily agreed to participate were included in the study.
Participants were randomly assigned to either the intervention group (education) or the control group (no education). The HPV education program is delivered in two 1-hour sessions using PowerPoint presentations and informational brochures developed from current literature and reviewed by experts in women's health nursing.
Data are collected before and after the educational sessions using a Personal Information Form and the HPV Knowledge Scale (HPV-KS), which measures participants' knowledge about HPV infection, vaccination, and screening. Statistical analyses will be conducted using SPSS 22.0, with descriptive statistics and inferential tests (paired-sample t-test, independent-sample t-test, repeated-measures ANOVA, and non-parametric equivalents) applied as appropriate. A p-value \< 0.05 will be considered statistically significant.
It is hypothesized that women receiving HPV education will demonstrate significantly higher post-intervention knowledge scores compared to those in the control group.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years of age or older,
Agreeing to participate in the study,
Not experiencing communication difficulties,
Female students who complete the data collection form in full will be included in the study.
Disqualifiers
Previously tested positive for HPV
History of cervical cancer
Unreachable
Not attending public education during the training period
Trial design
Design model
Parallel
Treatments tested in this trial
HPV Awareness Education Group
Other interventionWomen who agree to participate in the training will receive a total of two hours of HPV awareness training in two sessions on the predetermined training date. The HPV awareness training will be delivered using a PowerPoint presentation, and at the end of the training, a brochure created in line with the literature will be distributed to the participating women to ensure retention. The brochure will be prepared by the researcher based on current literature sources. Expert opinions will be sought from specialists in the field of obstetrics and gynecology nursing regarding the training content, and revisions will be made if necessary. The training content will include the definition of HPV, risk factors, etiology, screening, HPV vaccination, transmission and prevention methods, and treatment. The training topics will be prepared by the faculty members responsible for the research in accordance with the literature.
Treatment groups
110 Participants
are divided into 2 treatment groupsGroup A: HPV Awareness Education GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
HPV knowledge level measured by the Human Papillomavirus Knowledge Scale (HPV-BÖ)
his outcome will assess changes in participants' knowledge about HPV, HPV vaccination, HPV screening tests, and the national vaccination program using the HPV Knowledge Scale adapted to Turkish women. The scale consists of 33 items scored as 0-33, with higher scores indicating higher knowledge.
Time frame
Baseline (pre-test) and immediately after the education session (post-test)Secondary outcomes
1
General HPV knowledge measured by the HPV Knowledge Scale (HPV-BÖ) - Subscale 1
Evaluates participants' general knowledge about HPV infection using the related subscale of the HPV Knowledge Scale
Time frame
Baseline and immediately after the intervention2
Knowledge of HPV screening tests measured by the HPV Knowledge Scale (HPV-BÖ) - Subscale 2
Assesses changes in knowledge related to HPV screening tests
Time frame
Baseline and immediately after the intervention3
Knowledge of HPV vaccination measured by the HPV Knowledge Scale (HPV-BÖ) - Subscale 3
Assesses participants' knowledge about HPV vaccination and recommendations.
Time frame
Baseline and immediately after the intervention4
Knowledge of the national HPV vaccination program measured by the HPV Knowledge Scale (HPV-BÖ) - Subscale 4
Evaluates changes in awareness regarding the national HPV vaccination program.
Time frame
Baseline and immediately after the interventionLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: